Federated Hermes, Inc. Medpace Holdings, Inc. Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 19,736 shares of MEDP stock, worth $6.65 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

19,736

Previous 18,965 4.07%

Holding current value

$6.65 Million

Previous $7.66 Million 6.05%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$372.0 - $424.34 $286,812 - $327,166	771 Added 4.07%	19,736 $8.13 Million
Q1 2024 May 14, 2024	BUY	$284.87 - $413.31 $327,885 - $475,719	1,151 Added 6.46%	18,965 $7.66 Million
Q4 2023 Jan 31, 2024	SELL	$227.52 - $312.68 $2.56 Million - $3.52 Million	-11,261 Reduced 38.73%	17,814 $5.46 Million
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $4.23 Million - $5.09 Million	18,088 Added 164.63%	29,075 $7.04 Million
Q2 2023 Aug 14, 2023	SELL	$187.26 - $240.17 $76,214 - $97,749	-407 Reduced 3.57%	10,987 $2.64 Million
Q1 2023 May 08, 2023	BUY	$174.31 - $239.52 $1.24 Million - $1.7 Million	7,114 Added 166.21%	11,394 $2.14 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $57,397 - $84,963	-375 Reduced 8.06%	4,280 $909,000
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $73,290 - $92,157	-505 Reduced 9.79%	4,655 $732,000
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $205,064 - $264,647	-1,575 Reduced 23.39%	5,160 $772,000
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $377,587 - $582,708	-2,719 Reduced 28.76%	6,735 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $353,419 - $440,758	1,934 Added 25.72%	9,454 $2.06 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $3.29 Million - $3.83 Million	-19,318 Reduced 71.98%	7,520 $1.42 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $4.66 Million - $5.71 Million	-29,388 Reduced 52.27%	26,838 $4.74 Million
Q1 2021 May 13, 2021	BUY	$132.02 - $168.26 $6.4 Million - $8.16 Million	48,487 Added 626.53%	56,226 $9.23 Million
Q4 2020 Feb 12, 2021	SELL	$109.38 - $149.19 $14.7 Million - $20 Million	-134,354 Reduced 94.55%	7,739 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$92.95 - $130.61 $6.66 Million - $9.36 Million	-71,629 Reduced 33.52%	142,093 $15.9 Million
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $5.11 Million - $7.18 Million	-74,992 Reduced 25.97%	213,722 $19.9 Million
Q1 2020 May 13, 2020	SELL	$61.71 - $101.95 $13.9 Million - $23 Million	-225,477 Reduced 43.85%	288,714 $21.2 Million
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $19.9 Million - $24 Million	283,854 Added 123.23%	514,191 $43.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $8.71 Million - $12 Million	139,562 Added 153.74%	230,337 $19.4 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $429,495 - $523,817	8,007 Added 9.67%	90,775 $5.94 Million
Q1 2019 May 10, 2019	SELL	$49.38 - $70.58 $7.83 Million - $11.2 Million	-158,496 Reduced 65.69%	82,768 $4.88 Million
Q4 2018 Feb 13, 2019	BUY	$46.97 - $63.98 $4.51 Million - $6.14 Million	96,039 Added 66.13%	241,264 $12.8 Million
Q3 2018 Nov 13, 2018	BUY	$43.25 - $63.74 $610,041 - $899,052	14,105 Added 10.76%	145,225 $8.7 Million
Q2 2018 Aug 10, 2018	SELL	$34.03 - $45.46 $1.42 Million - $1.9 Million	-41,693 Reduced 24.13%	131,120 $5.64 Million
Q1 2018 May 09, 2018	SELL	$32.03 - $39.05 $633,617 - $772,487	-19,782 Reduced 10.27%	172,813 $6.03 Million
Q4 2017 Feb 14, 2018	BUY	$32.46 - $38.31 $10,906 - $12,872	336 Added 0.17%	192,595 $0
Q3 2017 Nov 13, 2017	BUY	$27.43 - $33.11 $5.27 Million - $6.37 Million	192,259	192,259 $6.13 Million

Others Institutions Holding MEDP

# of Institutions

653

Shares Held

25.6M

Call Options Held

38.7K

Put Options Held

79.5K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.5B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Medpace Holdings, Inc. Transaction History